496 related articles for article (PubMed ID: 9643314)
21. High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients.
Allenbach Y; Seror R; Pagnoux C; Teixeira L; Guilpain P; Guillevin L;
Ann Rheum Dis; 2009 Apr; 68(4):564-7. PubMed ID: 19015208
[TBL] [Abstract][Full Text] [Related]
22. Vasculitis in childhood.
Roberti I; Reisman L; Churg J
Pediatr Nephrol; 1993 Aug; 7(4):479-89. PubMed ID: 8104458
[TBL] [Abstract][Full Text] [Related]
23. Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature.
Rothschild PR; Pagnoux C; Seror R; Brézin AP; Delair E; Guillevin L
Semin Arthritis Rheum; 2013 Apr; 42(5):507-14. PubMed ID: 23270762
[TBL] [Abstract][Full Text] [Related]
24. Microscopic polyangiitis (microscopic polyarteritis).
Jennette JC; Thomas DB; Falk RJ
Semin Diagn Pathol; 2001 Feb; 18(1):3-13. PubMed ID: 11296991
[TBL] [Abstract][Full Text] [Related]
25. Distinguishing polyarteritis nodosa from microscopic polyangiitis and implications for treatment.
Guillevin L; Lhote F
Curr Opin Rheumatol; 1995 Jan; 7(1):20-4. PubMed ID: 7718418
[TBL] [Abstract][Full Text] [Related]
26. Pregnancies in systemic necrotizing vasculitides: report on 12 women and their 20 pregnancies.
Pagnoux C; Le Guern V; Goffinet F; Diot E; Limal N; Pannier E; Warzocha U; Tsatsaris V; Dhote R; Karras A; Cohen P; Damade R; Mouthon L; Guillevin L
Rheumatology (Oxford); 2011 May; 50(5):953-61. PubMed ID: 21183452
[TBL] [Abstract][Full Text] [Related]
27. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients.
Guillevin L; Lhote F; Cohen P; Jarrousse B; Lortholary O; Généreau T; Léon A; Bussel A
Arthritis Rheum; 1995 Nov; 38(11):1638-45. PubMed ID: 7488285
[TBL] [Abstract][Full Text] [Related]
28. The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI).
Mohammad AJ; Bakoush O; Sturfelt G; Segelmark M
Scand J Rheumatol; 2009; 38(4):268-75. PubMed ID: 19296401
[TBL] [Abstract][Full Text] [Related]
29. Polyarteritis Nodosa Neurologic Manifestations.
de Boysson H; Guillevin L
Neurol Clin; 2019 May; 37(2):345-357. PubMed ID: 30952413
[TBL] [Abstract][Full Text] [Related]
30. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.
Guillevin L; Pagnoux C; Seror R; Mahr A; Mouthon L; Toumelin PL;
Medicine (Baltimore); 2011 Jan; 90(1):19-27. PubMed ID: 21200183
[TBL] [Abstract][Full Text] [Related]
31. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment.
Guillevin L; Lhote F; Gherardi R
Neurol Clin; 1997 Nov; 15(4):865-86. PubMed ID: 9367969
[TBL] [Abstract][Full Text] [Related]
32. Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis.
Frankel SK; Sullivan EJ; Brown KK
Crit Care Clin; 2002 Oct; 18(4):855-79. PubMed ID: 12418444
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.
Guillevin L; Lhote F; Gayraud M; Cohen P; Jarrousse B; Lortholary O; Thibult N; Casassus P
Medicine (Baltimore); 1996 Jan; 75(1):17-28. PubMed ID: 8569467
[TBL] [Abstract][Full Text] [Related]
34. Antineutrophil cytoplasmic antibodies (ANCA) and abnormal angiograms in polyarteritis nodosa and Churg-Strauss syndrome: indications for the diagnosis of microscopic polyangiitis.
Guillevin L; Lhote F; Brauner M; Casassus P
Ann Med Interne (Paris); 1995; 146(8):548-50. PubMed ID: 8734079
[TBL] [Abstract][Full Text] [Related]
35. Classification and management of necrotising vasculitides.
Guillevin L; Lhote F
Drugs; 1997 May; 53(5):805-16. PubMed ID: 9129867
[TBL] [Abstract][Full Text] [Related]
36. Clinical review: Vasculitis on the intensive care unit -- part 2: treatment and prognosis.
Semple D; Keogh J; Forni L; Venn R
Crit Care; 2005 Apr; 9(2):193-7. PubMed ID: 15774077
[TBL] [Abstract][Full Text] [Related]
37. Renal involvement in systemic vasculitis. Seminar. Vimercate, Italy, September 22, 1990.
Contrib Nephrol; 1991; 94():1-201. PubMed ID: 1687268
[No Abstract] [Full Text] [Related]
38. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
Puéchal X; Pagnoux C; Baron G; Quémeneur T; Néel A; Agard C; Lifermann F; Liozon E; Ruivard M; Godmer P; Limal N; Mékinian A; Papo T; Ruppert AM; Bourgarit A; Bienvenu B; Geffray L; Saraux JL; Diot E; Crestani B; Delbrel X; Sailler L; Cohen P; Le Guern V; Terrier B; Groh M; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
Arthritis Rheumatol; 2017 Nov; 69(11):2175-2186. PubMed ID: 28678392
[TBL] [Abstract][Full Text] [Related]
39. Primary systemic vasculitis: clinical features and mortality.
Lane SE; Watts RA; Shepstone L; Scott DG
QJM; 2005 Feb; 98(2):97-111. PubMed ID: 15655098
[TBL] [Abstract][Full Text] [Related]
40. Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients.
Boki KA; Dafni U; Karpouzas GA; Papasteriades C; Drosos AA; Moutsopoulos HM
Br J Rheumatol; 1997 Oct; 36(10):1059-66. PubMed ID: 9374922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
